Loading...
OTCM
INBP
Market cap10mUSD
Jul 10, Last price  
0.34USD
1D
-0.70%
1Q
13.90%
Jan 2017
50.11%
Name

Integrated Biopharma Inc

Chart & Performance

D1W1MN
P/E
91.98
P/S
0.20
EPS
0.00
Div Yield, %
Shrs. gr., 5y
0.86%
Rev. gr., 5y
0.14%
Revenues
50m
-0.70%
32,735,81357,820,46660,160,00049,940,00039,367,00037,019,00025,133,00036,604,00033,623,00033,683,00037,488,00042,214,00046,954,00043,710,00049,977,00052,769,00063,559,00056,246,00050,672,00050,317,000
Net income
112k
P
-8,580,2338,431,752-2,044,000-18,167,000-18,176,000-5,535,000-2,281,000-2,713,00093,000131,000735,000958,0002,346,000679,0001,688,0004,108,0008,013,0003,838,000-34,000112,000
CFO
943k
-23.46%
-4,538,1264,677,885-5,502,000-4,298,000-2,752,000-116,000390,000-771,000-1,438,0001,877,000-113,000-594,000397,0001,168,000328,0001,339,0003,050,0004,091,0001,232,000943,000
Dividend
Aug 19, 20080.5 USD/sh
Earnings
Sep 18, 2025

Profile

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
IPO date
Oct 30, 1996
Employees
147
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
50,317
-0.70%
50,672
-9.91%
Cost of revenue
46,433
46,611
Unusual Expense (Income)
NOPBT
3,884
4,061
NOPBT Margin
7.72%
8.01%
Operating Taxes
156
134
Tax Rate
4.02%
3.30%
NOPAT
3,728
3,927
Net income
112
-429.41%
(34)
-100.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
13
4
BB yield
-0.20%
-0.04%
Debt
Debt current
1,904
1,860
Long-term debt
2,644
4,365
Deferred revenue
Other long-term liabilities
Net debt
2,871
4,909
Cash flow
Cash from operating activities
943
1,232
CAPEX
(553)
(116)
Cash from investing activities
(553)
(111)
Cash from financing activities
(29)
(136)
FCF
6,704
749
Balance
Cash
1,677
1,316
Long term investments
Excess cash
Stockholders' equity
(32,167)
(32,279)
Invested Capital
54,155
57,008
ROIC
6.71%
7.15%
ROCE
17.66%
16.42%
EV
Common stock shares outstanding
30,874
29,950
Price
0.21
-36.60%
0.33
-33.74%
Market cap
6,483
-34.64%
9,920
-38.60%
EV
9,354
14,829
EBITDA
5,105
5,215
EV/EBITDA
1.83
2.84
Interest
40
Interest/NOPBT
0.98%